BERGE ROLF has a total of 21 patent applications. Its first patent ever was published in 1995. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, foods and drinks and machines are THIA MEDICA AS, MD BIOALPHA and FOODSCIENCE CORP.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 8 | |
#2 | WIPO (World Intellectual Property Organization) | 5 | |
#3 | EPO (European Patent Office) | 3 | |
#4 | Australia | 2 | |
#5 | Canada | 1 | |
#6 | Republic of Korea | 1 | |
#7 | Norway | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Foods and drinks | |
#3 | Machines | |
#4 | Electrical machinery and energy | |
#5 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Foods | |
#4 | Special foods | |
#5 | Fodder | |
#6 | Unspecified technologies | |
#7 | Special electric heating or lighting | |
#8 | Climate change mitigation in buildings |
# | Name | Total Patents |
---|---|---|
#1 | Berge Rolf | 21 |
#2 | Songstad Jon | 8 |
#3 | Aukrust Pal | 2 |
#4 | Kleppe Gunnar | 1 |
#5 | Kristiansen Karsten | 1 |
Publication | Filing date | Title |
---|---|---|
AU7240398A | Use of non-beta-oxidizable fatty acid analogues for treatment of syndrome-x conditions | |
EP1232750A1 | Non-beta-oxidizable fatty acid analogues and their use for reduction of growth of cancer cells |